openPR Logo
Press release

Investigation announced for Investors in Embecta Corp. (NASDAQ: EMBC) over potential Wrongdoing

03-16-2023 01:53 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of investors in Embecta Corp. (NASDAQ: EMBC) shares over potential wrongdoing at Embecta Corp.

An investigation on behalf of investors in Embecta Corp. (NASDAQ: EMBC) shares over potential wrongdoing at Embecta Corp.

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Embecta Corp.

Investors who purchased shares of Embecta Corp. (NASDAQ: EMBC) certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Embecta directors breached their fiduciary duties and caused damage to the company and its shareholders.

Parsippany, NJ based Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. On December 20, 2022, Embecta Corp. released Fiscal 2022 Fourth Quarter and Full Year Financial Results. Among the items reported, Embecta stated that "an impairment charge of $58.9 million related to the abandonment of certain manufacturing production lines in the United States that are no longer expected to be completed, and a $5.5 million charge related to purchase commitments associated with the abandonment of the assets."

Shares of Embecta Corp. (NASDAQ: EMBC) declined from $36.64 per share on December 14, 2022, to as low as $24.11 per share on December 20, 2022.

Those who purchased shares of Embecta Corp. (NASDAQ: EMBC) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in Embecta Corp. (NASDAQ: EMBC) over potential Wrongdoing here

News-ID: 2977118 • Views:

More Releases from Shareholders Foundation

Investigation announced for Investors in FMC Corporation (NYSE: FMC) over potential Wrongdoing
Investigation announced for Investors in FMC Corporation (NYSE: FMC) over potent …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of FMC Corporation. Investors who are current long term investors in FMC Corporation (NYSE: FMC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: FMC stocks follows a lawsuit filed against FMC Corporation over
Investigation announced for Long-Term Investors who lost money with Advance Auto Parts, Inc. (NYSE: AAP)
Investigation announced for Long-Term Investors who lost money with Advance Auto …
An investigation was announced for long-term investors in shares of Advance Auto Parts, Inc. (NYSE: AAP) concerning potential breaches of fiduciary duties by certain directors of Advance Auto Parts, Inc. Investors who are current long term investors in Advance Auto Parts, Inc. (NYSE: AAP) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long
Investigation announced for Investors in Treace Medical Concepts, Inc. (NASDAQ: TMCI) over potential Wrongdoing
Investigation announced for Investors in Treace Medical Concepts, Inc. (NASDAQ: …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Treace Medical Concepts, Inc. Investors who purchased shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Treace Medical Concepts, Inc. directors breached their fiduciary duties and caused damage to the company and its
Deadline on May 20th coming up in Lawsuit for Investors in the Chemours Company (NYSE: CC)
Deadline on May 20th coming up in Lawsuit for Investors in the Chemours Company …
A deadline is coming up on May 20, 2024 in the lawsuit filed for certain investors of The Chemours Company (NYSE: CC) over alleged securities laws violations by The Chemours Company. Investors who purchased shares of The Chemours Company (NYSE: CC) have certain options and there are strict and short deadlines running. Deadline: May 20, 2024. NYSE: CC stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for Embecta

Diabetes Care Devices Market Biggest Innovation with Top Key Players -Abbott, F. …
The Diabetes Care Devices Market is expected to grow at a CAGR of 6.7% from 2021 to reach $31.9 billion by 2028. Increasing prevalence of diabetes, unhealthy lifestyle, product innovations in diabetes care, rising obesity rate, and development of new insulin delivery systems are the key factors driving steady growth of the global diabetes care devices market. Key Players in the Diabetes Care Devices market: Abbott, F. Hoffmann-La Roche Ltd, Novo Nordisk
Diabetes Care Devices Market Size, 2022 Global Business Trends, Share, Analysis …
The Diabetes Care Devices Market is predicted to reach US$ 32,255.9 million by 2031 from US$ 68,733.5 million in 2020, and to grow at a CAGR of 8.3% between the forecast period 2021 to 2031. Diabetes Care Devices Market 2022 research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying